# Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis

> **NCT04522505** · — · COMPLETED · sponsor: **Corestemchemon, Inc.** · enrollment: 6 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04522505
- **Lead sponsor:** Corestemchemon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-29
- **Primary completion:** 2024-02-07
- **Final completion:** 2024-07-22
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04522505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04522505, "Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04522505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*